While the company reports a current ratio of 3.45, the equity base remains fragile with retained earnings having recently turned negative at -$2.3M.
| Total Current Assets | 15.32M | 19.6M | 15.38M | 3.67M | 445.06K | 2.63M |
| Cash & Short-Term Investments | 6.8M | 8.62M | 6.66M | 1.2M | 293.51K | 55.89K |
| Cash Only | 6.8M | 8.62M | 6.66M | 1.2M | 293.51K | 55.89K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.15M | 5.29M | 3.55M | 66.22K | 3.92K | 1.97M |
| Days Sales Outstanding | 10.89 | 58.82 | 26.7 | 0.86 | 0.09 | 56.01 |
| Inventory | 0 | 0 | 5.17M | 2.4M | 0 | 471.46K |
| Days Inventory Outstanding | - | - | 41.26 | 33.54 | - | 14.06 |
| Other Current Assets | 0 | 0 | -5.17M | 0 | 0 | -342.24K |
| Total Non-Current Assets | 5.34M | 1.99M | 126.74K | 790.13K | 97.94K | 185.63K |
| Property, Plant & Equipment | 143.51K | 188.09K | 126.74K | 233.38K | 97.94K | 185.63K |
| Fixed Asset Turnover | 528.16x | 174.41x | 382.82x | 120.96x | 164.97x | 69.21x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 694.67K | 1.8M | 0 | 0 | 0 | 0 |
| Long-Term Investments | 4.5M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 556.75K | 0 | 0 |
| Total Assets | 20.66M | 21.6M | 15.51M | 4.46M | 542.99K | 2.81M |
| Asset Turnover | 4.59x | 1.52x | 3.13x | 6.32x | 29.76x | 4.57x |
| Asset Growth % | 537.61% | 39.27% | 247.35% | 722.15% | -80.7% | - |
| Total Current Liabilities | 4.44M | 3.89M | 3.87M | 2.58M | 2.01M | 4.68M |
| Accounts Payable | 162.68K | 153.87K | 653.69K | 27.34K | 1.27M | 2.92M |
| Days Payables Outstanding | 1.71 | 1.76 | 5.21 | 0.38 | 29.93 | 87.19 |
| Short-Term Debt | 1.31M | 1.69M | 833.52K | 511.41K | 439.4K | 178.82K |
| Deferred Revenue (Current) | 3.67M | 537.65K | 1.19M | 1.49M | 166.9K | 542.44K |
| Other Current Liabilities | 1.41K | 166.55K | 102.44K | 0 | 0 | 880.29K |
| Current Ratio | 3.45x | 5.05x | 3.98x | 1.43x | 0.22x | 0.56x |
| Quick Ratio | 3.45x | 5.05x | 2.64x | 0.49x | 0.22x | 0.46x |
| Cash Conversion Cycle | 9.17 | - | 62.75 | 34.02 | - | -17.13 |
| Total Non-Current Liabilities | 266.05K | 333.82K | 368.04K | 321.21K | 0 | 68.56K |
| Long-Term Debt | 266.05K | 307.32K | 368.04K | 249.11K | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 68.56K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 26.5K | 0 | 72.1K | 0 | 0 |
| Total Liabilities | 4.7M | 4.22M | 4.23M | 2.9M | 2.01M | 4.74M |
| Total Debt | 1.6M | 1.99M | 1.2M | 850.06K | 505.4K | 335.03K |
| Net Debt | -5.2M | -6.62M | -5.45M | -353.14K | 211.89K | 1.09M |
| Debt / Equity | 0.10x | 0.11x | 0.11x | 0.54x | - | - |
| Debt / EBITDA | -0.27x | - | 0.70x | 0.71x | 1.87x | 1.01x |
| Net Debt / EBITDA | 0.89x | - | -3.16x | -0.29x | 0.78x | 3.29x |
| Interest Coverage | -7.48x | 91.25x | 43.13x | 57.95x | 27.06x | 62.72x |
| Total Equity | 15.96M | 17.38M | 11.27M | 1.57M | -1.47M | -1.93M |
| Equity Growth % | 1647.43% | 54.16% | 619.56% | 206.88% | 24.1% | - |
| Book Value per Share | 3.56 | 7.25 | 0.92 | 0.14 | -0.15 | -0.19 |
| Total Shareholders' Equity | 15.96M | 17.38M | 11.27M | 1.57M | -1.47M | -1.93M |
| Common Stock | 148.61K | 7.24K | 3.22K | 2.95K | 2.54K | 2.54K |
| Retained Earnings | -2.28M | 4.6M | 723.21K | -568.46K | -1.54M | -1.78M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 67.97K | -45.52K | -44.39K | -44.78K | -112.96K | -176K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Operational cash flow volatility
According to recent financial statements, HAO has transitioned from a net liability position in 2022 to a positive equity base of $16.0M by 2026Q2, though this improvement appears driven more by capital injections or accounting adjustments than by consistent, profitable growth in core operations.
The shift from negative equity to a positive position suggests a stabilization of the capital structure, yet the underlying business remains in a state of contraction. Investors should monitor whether this equity growth is sustainable or if it remains vulnerable to the persistent revenue declines observed in the core advertising segment.
Based on reported figures, HAO maintains a current ratio of 3.45 as of 2026Q2, providing a superficial appearance of liquidity, yet this buffer is largely comprised of cash reserves that may be rapidly depleted if the company fails to reverse its negative operating cash flow trends.
While the current ratio suggests an ability to cover short-term obligations, the lack of recurring revenue streams makes this liquidity position precarious. The reliance on cash on hand to fund ongoing operations warrants further investigation into the company's long-term solvency if the current revenue contraction persists.
As indicated by the balance sheet data, HAO's equity base of $16.0M is heavily influenced by volatile retained earnings, which have fluctuated significantly and recently turned negative at -$2.3M, suggesting that the company has yet to establish a reliable foundation of internally generated capital.
The instability in retained earnings reflects the difficulty the company faces in maintaining profitability within its niche advertising model. This lack of consistent earnings accumulation implies that the equity base may be subject to further erosion if the company cannot achieve a sustainable turnaround in its operating margins.
Based on the provided balance sheet, the emergence of $694.7K in goodwill as of 2026Q2 introduces a new layer of impairment risk, particularly given the company's recent -32.39% revenue decline and the highly competitive nature of the Chinese digital advertising market for healthcare services.
The introduction of intangible assets onto the balance sheet warrants close scrutiny, as it may indicate past acquisitions that are not yet delivering the expected synergies. If the core business continues to struggle, these assets could be subject to future write-downs, further impacting the company's reported equity position.
Quick answers to the most common questions about buying HAO stock.
As of 2025, Haoxi Health Technology Limited (HAO) had total assets of $21.6M including $19.6M in current assets.
Haoxi Health Technology Limited (HAO) carries total debt of $2.0M, offset by $8.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Haoxi Health Technology Limited (HAO) has total shareholders' equity (book value) of $17.4M ($7.25 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Haoxi Health Technology Limited (HAO) reported a current ratio of 5.05x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.